SUBSCRIPTION AGREEMENTSubscription Agreement • May 29th, 2020 • Cytonics Corp • Biological products, (no disgnostic substances) • Florida
The securities offered hereby are highly speculative. Investing in shares of Cytonics Corporation involves significant risks. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that such investment could be illiquid for an indefinite period of time. No public market currently exists for the securities, and if a public market develops following this offering, it may not continue.
EXCLUSIVE SALES, MARKETING, MANUFACTURING AND DISTRIBUTION AGREEMENT FOR HUMAN MARKETExclusive Sales, Marketing, Manufacturing and Distribution Agreement • May 29th, 2020 • Cytonics Corp • Biological products, (no disgnostic substances) • Florida
Cytonics Corporation (“Cytonics”), a Florida Corporation, with principal place of business at 658 W. Indiantown Road, Suite 214, Jupiter, FL 33458, and Christie Medical Holdings (“CMH”), a [Delaware Limited Liability Company], with principal place of business at 200 Technology Park , Suite 1040, Lake Mary, FL 32746]. Cytonics and CMH shall each be referred to herein as a “Party” and collectively as “Parties”.
